Search Form
First, enter a politician or zip code
Now, choose a category
 

Elijah Cummings' Public Statements on Issue: Business and Consumers

Office: U.S. House (MD) - District 7, Democratic
On The Ballot: Running, Democratic for U.S. House - District 7
Date Title
Jan. 21, 2016 Tuesday: Oversight Committee Holds Drug Pricing Hearing Long Sought by Cummings
Dec. 18, 2015 Cummings Issues Statement on Arrest and Resignation of Martin Shkreli
Dec. 17, 2015 Skyrocketing Generic Drug Prices Cost Taxpayers $1.4 Billion, New Report Finds
Dec. 16, 2015 Letter to J. Michael Pearson, Chairman and CEO, Valeant Pharmaceuticals International Inc. - Demanding Documents and Interviews From Valeant Ahead of Oversight Hearing
Dec. 2, 2015 Letter to Martin Shkreli, Chief Executive Officer, Turing Pharmacueticals, LLC - Fake "Price Cut" for Critical Drug
Nov. 19, 2015 Letter to Claudia Rogers, Acting Chief Counsel for Advocacy, Office of Advocacy - Regulation of Small Business
Nov. 16, 2015 Letter to J. Michael Pearson, Chairman and CEO, Valeant Pharmaceuticals International Inc. - Business Practices
Oct. 9, 2015 Sanders and Cummings Denounce Continued Prescription Drug Price Gouging
Sept. 28, 2015 Letter to Jason Chaffetz, Chairman of the Committee on Oversight and Government Reform, and Bob Goodlatte, Chairman for the Committee on the Judiciary - Call to Subpoena Valeant
Sept. 23, 2015 Letter to Martin Shkreli, CEO of Turing Pharmaceuticals - Price Increases Impact on AIDS Patients
Sept. 22, 2015 Letter to Jason Chaffetz, Chairman of the Committee on Oversight and Government Reform - Hearing on Overnight Price Increases for Life-Saving Drugs
Sept. 21, 2015 Letter to Martin Shkreli, CEO of Turing Pharmaceuticals - Price Increases for Daraprim
Sept. 10, 2015 Press Conference: Prescription Drug Affordability Act September 10, 2015
Sept. 10, 2015 Sanders, Cummings Introduce Comprehensive Legislation to Lower Soaring Drug Prices
Sept. 1, 2015 Efforts by Casey, Wyden, and Cummings Lead to GAO Study of CMS Nursing Home Rating System
Aug. 31, 2015 Letter to David Sutton, CFO of Warner West Pharmacy and Supplies - Insurance Claims for Nutritional Supplements
Aug. 31, 2015 Letter to Larry Merlo, President and CEO of CVS Health - Insurance Claims for Nutritional Supplements
Aug. 27, 2015 Letter to Michael Borkowski, CEO of Access Funding - Predatory Buy-Outs of Structured Settlements
Aug. 26, 2015 Letter to Richard Cordray, Director of the Consumer Financial Protection Bureau - Small Business Lending Data
Aug. 20, 2015 Cummings Issues Detailed Statement on New Report on Skyrocketing Drug Prices
Aug. 20, 2015 Letter to David Daleiden, CEO of the Center for Medical Progress - Planned Parenthood Video
July 23, 2015 Cummings Applauds Maryland AG for Moving Aggressively to Combat Drug Overcharging
Feb. 24, 2015 Leading Economists Warn About Challenges Facing Middle Class
Jan. 21, 2015 Cummings Applauds President's Focus on Middle Class Economics
Jan. 1, 2015 Issue Position: Financial Regulatory Reform
Jan. 1, 2015 Issue Position: Economy
Nov. 20, 2014 Sanders and Cummings Introduce Legislation to Require Drug Company Rebates for Generic Drugs
Nov. 20, 2014 Hearing of the Primary Health and Aging Subcommittee of the Senate Health, Education, Labor, and Pensions Committee - Why Are Some Generic Drugs Skyrocketing In Price?
Nov. 12, 2014 Letter to Frank Blake, Chairman and CEO of The Home Depot - Seeking Briefings and Documents on Troubling Increase in Cyber-Attacks
Nov. 12, 2014 Letter to Wayne Smith, Chairman, President, and CEO of Community Health Systems - Seeking Briefings and Documents on Troubling Increase in Cyber-Attacks
Nov. 12, 2014 Letter to Alasdair James, President and CEO of Kmart Corporation - Seeking Briefings and Documents on Troubling Increase in Cyber-Attacks
Nov. 12, 2014 Letter to Jonathan Nelson, CEO of Providence Equity Partners, and Jeffrey Campbell, President and CEO of Altegrity - Seeking Briefings and Documents on Troubling Increase in Cyber-Attacks
Nov. 12, 2014 Letter to Brian Cornell, Chairman and CEO of Target Corporation - Seeking Briefings and Documents on Troubling Increase in Cyber-Attacks
Nov. 3, 2014 Cummings Receives Service Award from APL Maritime
Oct. 27, 2014 Letter to Mary Jo White, Chairman of the Securities and Exchange Commission - Protecting Corporate Whistleblowers
Oct. 7, 2014 Letter to Darrell Issa, Chairman of the House Committee on Oversight and Government Reform - Requesting Hearing on Data Security Breach at JPMorgan Chase
Oct. 6, 2014 Cummings Commends CMS for Improving Nursing Home Rating System
Oct. 2, 2014 Letter to Carole Ben-Maimon, President of Global Pharmaceuticals - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Brian Lortie, President at Endo International PLC - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Umang Vohra, Executive Vice President of Dr. Reddy's Laboratories LTD - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Brenton Saunders, CEO and President of Actavis PLC - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Jeffrey Glazer, President and CEO of Heritage Pharmaceuticals - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Jeffrey Watson, President of Apotex Corporation - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Dilip Shanghvi, Managing Director of Sun Pharmaceutical Industries - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Cummings and Sanders Investigate Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Paul Campanelli, CEO of Par Pharmaceutical Companies - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Erez Vigodman, President and CEO of Teva Pharmaceutical Industries - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Michael Raya, President and CEO of West-Ward Pharmaceutical Corporation - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Jeffrey Aronin, Chairman and CEO of Marathon Pharmaceuticals - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Arthur Bedrosian, President and CEO of Lannett Company - Investigating Staggering Price Increases for Generic Drugs
Skip to top
Back to top